Skip to main content

Strictly Adhere to COVID-19 Regulations During Festivals, Mamata Banerjee Urges People

Banerjee, who was speaking after a cabinet meeting, said I ask everybody to follow the COVID-19 safety protocols during the festive season. There are instance of community transmission of novel coronavirus and also the contagion becoming air-borne.

West bengal Chief Minister Mamata Banerjee on Monday urged people to strictly adhere to the COVID-19 regulations during the upcoming festive season as there are instances of the virus becoming air-borne and community transmission of the contagion in the state. 

Banerjee, who was speaking after a cabinet meeting, said "I ask everybody to follow the COVID-19 safety protocols during the festive season. There are instance of community transmission of novel coronavirus and also the contagion becoming air-borne." 

"I request Durga Puja Committees to not allow people without masks in pandals. They should be kept in a separate zone. If puja committees can give masks then it's fine. But we can't expect everyone to do the same," she said

"Delhi did not give permission for celebrations except in CR Park. Other states like, Uttar Pradesh didn't even allow. We will allow celebrations. But my only request is that everyone should wear masks and follow all precautionary steps," the CM added.

State Chief secretary Alapan Bandopadhyay said measures are being taken bring down the cost of coronavirus tests and treatment



Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...